Cargando…

A panel of emerging EMT genes identified in malignant mesothelioma

Malignant mesothelioma (MESO) is a highly aggressive cancer with poor prognosis. Epithelial–mesenchymal transition (EMT) is a critical process in malignancies involved in tumor angiogenesis, progression, invasion and metastasis, immunosuppressive microenvironment and therapy resistance. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Licun, Amjad, Shaheer, Yun, Hana, Mani, Sendurai, de Perrot, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770645/ https://www.ncbi.nlm.nih.gov/pubmed/35046456 http://dx.doi.org/10.1038/s41598-022-04973-x

Ejemplares similares

Prognostic Value of EMT Gene Signature in Malignant Mesothelioma
por: Wu, Licun, et al.
Publicado: (2023)

Omics Overview of the SPARC Gene in Mesothelioma
por: Wu, Licun, et al.
Publicado: (2023)

IRF3 Knockout Results in Partial or Complete Rejection of Murine Mesothelioma
por: Aoki, Masaya, et al.
Publicado: (2021)

Defining and targeting tumor-associated macrophages in malignant mesothelioma
por: Wu, Licun, et al.
Publicado: (2023)

Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells
por: Blum, Walter, et al.
Publicado: (2017)

Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma
por: Chan, Meilin, et al.
Publicado: (2021)

Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesothelioma
por: Zhang, Chengke, et al.
Publicado: (2018)

Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model
por: Wu, Licun, et al.
Publicado: (2015)

Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line
por: Blum, Walter, et al.
Publicado: (2015)

The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma
por: Ramundo, Valeria, et al.
Publicado: (2021)

EMT-induced metabolite signature identifies poor clinical outcome
por: Bhowmik, Salil Kumar, et al.
Publicado: (2015)

Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma
por: Kato, Tatsuya, et al.
Publicado: (2018)

Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma
por: Wu, Licun, et al.
Publicado: (2018)

Editorial: Emerging Therapies for Malignant Mesothelioma
por: van Zandwijk, Nico, et al.
Publicado: (2020)

Calretinin promotes invasiveness and EMT in malignant mesothelioma cells involving the activation of the FAK signaling pathway
por: Wörthmüller, Janine, et al.
Publicado: (2018)

S100A4 Is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant Mesothelioma
por: Nader, Joëlle S., et al.
Publicado: (2020)

Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma
por: Hudson, Amanda L., et al.
Publicado: (2014)

Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies
por: Pouliquen, Daniel L., et al.
Publicado: (2022)

Coupling the modules of EMT and stemness: A tunable ‘stemness window’ model
por: Jolly, Mohit Kumar, et al.
Publicado: (2015)

Identification of a new potential plasmatic biomarker panel for the diagnosis of malignant pleural mesothelioma
por: Ferrari, Luca, et al.
Publicado: (2022)

Carbon Nanotubes: A Summary of Beneficial and Dangerous Aspects of an Increasingly Popular Group of Nanomaterials
por: Zhang, Chengke, et al.
Publicado: (2021)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Malignant mesothelioma
por: Ahmed, Ishtiaq, et al.
Publicado: (2013)

Malignant Mesothelioma
por: Pouliquen, Daniel L., et al.
Publicado: (2021)

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022)

Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
por: Gray, Steven G.
Publicado: (2021)

A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma
por: Duong, Bill T.V., et al.
Publicado: (2020)

Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing
por: Deshmukh, Abhijeet P., et al.
Publicado: (2021)

Distinguishing mechanisms underlying EMT tristability
por: Jia, Dongya, et al.
Publicado: (2017)

Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
por: Morani, Federica, et al.
Publicado: (2021)

Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
por: Cantini, Luca, et al.
Publicado: (2020)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Mesothelium and Malignant Mesothelioma
por: Hiriart, Emilye, et al.
Publicado: (2019)

Malignant paratesticular mesothelioma
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2014)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment
por: Hariharan, Ananya, et al.
Publicado: (2022)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Differentially expressed alternatively spliced genes in Malignant Pleural Mesothelioma identified using massively parallel transcriptome sequencing
por: Dong, Lingsheng, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kj50rlqdrm7m0hhhc28l653sfu